As of 2026-04-14, the Relative Valuation of ALX Oncology Holdings Inc (ALXO) is (16.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.75 USD, the upside of ALX Oncology Holdings Inc based on Relative Valuation is -1065.9%.
The range of the Relative Valuation is (15.72) - (17.82) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.7x - 25.3x | 22.4x |
| Forward P/E multiples | 20.3x - 23.1x | 21.4x |
| Fair Price | (15.72) - (17.82) | (16.90) |
| Upside | -998.1% - -1118.2% | -1065.9% |
| Date | P/E |
| 2026-04-10 | -2.20 |
| 2026-04-09 | -2.20 |
| 2026-04-08 | -2.45 |
| 2026-04-07 | -2.37 |
| 2026-04-06 | -2.54 |
| 2026-04-02 | -2.55 |
| 2026-04-01 | -2.56 |
| 2026-03-31 | -2.59 |
| 2026-03-30 | -2.47 |
| 2026-03-27 | -2.64 |
| 2026-03-26 | -2.64 |
| 2026-03-25 | -2.64 |
| 2026-03-24 | -2.64 |
| 2026-03-23 | -2.85 |
| 2026-03-20 | -2.82 |
| 2026-03-19 | -2.83 |
| 2026-03-18 | -2.78 |
| 2026-03-17 | -2.81 |
| 2026-03-16 | -2.69 |
| 2026-03-13 | -2.56 |
| 2026-03-12 | -2.61 |
| 2026-03-11 | -2.78 |
| 2026-03-10 | -2.64 |
| 2026-03-09 | -2.76 |
| 2026-03-06 | -2.86 |
| 2026-03-05 | -2.76 |
| 2026-03-04 | -2.83 |
| 2026-03-03 | -2.68 |
| 2026-03-02 | -2.74 |
| 2026-02-27 | -2.73 |
| 2026-02-26 | -3.04 |
| 2026-02-25 | -3.13 |
| 2026-02-24 | -3.17 |
| 2026-02-23 | -3.13 |
| 2026-02-20 | -3.17 |
| 2026-02-19 | -3.36 |
| 2026-02-18 | -3.00 |
| 2026-02-17 | -2.94 |
| 2026-02-13 | -2.86 |
| 2026-02-12 | -3.11 |
| 2026-02-11 | -3.21 |
| 2026-02-10 | -3.30 |
| 2026-02-09 | -3.03 |
| 2026-02-06 | -2.65 |
| 2026-02-05 | -2.67 |
| 2026-02-04 | -2.60 |
| 2026-02-03 | -2.42 |
| 2026-02-02 | -2.17 |
| 2026-01-30 | -2.25 |
| 2026-01-29 | -2.03 |